Please login to the form below

Not currently logged in

Eiger BioPharmaceuticals

This page shows the latest Eiger BioPharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Eiger BioPharmaceuticals reports positive phase 3 results for COVID-19 treatment

Eiger BioPharmaceuticals reports positive phase 3 results for COVID-19 treatment

US-based Eiger BioPharmaceuticals’ investigational agent, peginterferon lambda (Lambda), significantly reduces the number of clinical events in COVID-19 patients with mild to moderate cases, according to new phase 3 data ... chief executive officer,

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Evoke Mind+Matter Evoke Mind+Matter

    They include: Aerogen, Akcea, Allakos, Alexion, Amylyx Pharmaceuticals, Astellas, Baxter Healthcare, Bayer, Biocryst, Biogen, Biomarin, Bio-Oil, Boehringer Ingelheim, Cryoport, Colgate Palmolive, CSL Behring, Eiger BioPharmaceuticals, EIT Health,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts


Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...